L. Falchi, J. M. Baron, C. A. Orlikowski, and A. Ferrajoli, “BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA”, Mediterr J Hematol Infect Dis, vol. 8, p. e2016011, Feb. 2016.